Rainier Acquisition Corporation(NASDAQ) RNAQW

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2026)-23%
5 YearN/A
1 YearN/A
1 MonthN/A
$0.40
+0.00%
+0.00Today
Rainier Acquisition Corporation last closing stock price
MetricPriceDate
Last closeUSD 0.402026-10-09
Rainier Acquisition Corporation stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-4.79%USD 0.422026-10-01
Since inception-23.1%USD 0.522026-09-15

Rainier Acquisition Corporation Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-6.15 (Low)

Price

$0.40

Volume

1,406

Open

$0.40

Previous Close

$0.40

Daily Range

$0.40 - $0.40

52-Week Range

$0.40 - $0.54

Estimated Earnings Date

N/A

RNAQW News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Rainier Acquisition Corporation

Rainier Acquisition Corporation Warrants operates as a blank check company focused on effecting mergers and acquisitions, particularly in the global life sciences sector. The company aims to identify opportunities in therapeutics, diagnostics, genomics, precision medicine, and related fields.

Products and Services
  • Focus on mergers and acquisitions in life sciences
  • Targeting innovative companies in therapeutics and diagnostics
  • Exploring opportunities in precision medicine and research services
Growth Outlook
  • Life sciences market projected to grow significantly in the coming years
  • Increased demand for innovative healthcare solutions drives potential acquisitions
  • Strategic focus on high-growth sectors enhances investment opportunities
Financial Highlights
  • Market capitalization of approximately $862,284
  • Stock price range between $0.3999 and $0.54 over the past year
  • Average trading volume of 7,725 shares indicates investor interest
Rainier Acquisition Corporation Warrants is positioned to capitalize on the expanding life sciences market, which is expected to see substantial growth driven by advancements in healthcare technology and increasing demand for innovative solutions. The company's strategic focus on high-potential sectors such as therapeutics and diagnostics enhances its attractiveness to potential investors. With a solid market capitalization and consistent trading volume, Rainier Acquisition Corporation Warrants presents an intriguing opportunity for those interested in the evolving landscape of the life sciences industry.
AI Generated • Oct 13, 2026

Industry

Capital Markets

Headquarters

New York, NY 10119, US

RNAQW Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

0.00%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

0

Volume

1.41K

Avg. Volume

6.72K

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Rainier Acquisition Corporation Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Total Cash

N/A

N/A

Total Debt

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,721.68+0.00%
^DJIDJI
$52,076.17+0.01%
^IXICNASDAQ
$26,579.10-0.00%
BTCBitcoin
$82,037.00+0.01%

Trending Stocks

Symbol / CompanyPricePrice Chg
CCCCCC Intelligent Solutions
$7.63-0.13%
INTCIntel
$95.37-2.80%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$107.35-2.89%
CRWVCoreWeave
$69.69+5.94%

Questions About RNAQW

What is the current price of Rainier Acquisition Corporation?

Rainier Acquisition Corporation is trading at $0.40 per share.

What is the 52-week range for Rainier Acquisition Corporation?

Over the past 52 weeks, Rainier Acquisition Corporation has traded between $0.40 and $0.54.

How much debt does Rainier Acquisition Corporation have?

Rainier Acquisition Corporation total debt is unavailable.

How much cash does Rainier Acquisition Corporation have on hand?

Rainier Acquisition Corporation does not have cash on hand data available.

What is Rainier Acquisition Corporation’s dividend yield?

Rainier Acquisition Corporation does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.